Literature DB >> 14630472

Particle-hemodynamics modeling of the distal end-to-side femoral bypass: effects of graft caliber and graft-end cut.

P Worth Longest1, Clement Kleinstreuer.   

Abstract

Late-stage occlusions of peripheral synthetic bypass grafts are frequently due to intimal hyperplasia and/or thrombosis at the distal anastomosis, resulting in unacceptably high failure rates. It has been widely established that hemodynamic and blood particle interactions with the vascular surface as well as surgical injury and compliance mismatch are inciting mechanisms capable of eliciting various cellular level responses associated with distal anastomotic intimal hyperplasia (IH) formation. Primary geometric factors influencing anastomotic hemodynamics include the graft-to-artery diameter ratio and graft-hood shape, which are determined by the graft caliber and initial graft-end cut selected by the vascular surgeon. In this study, the particle-hemodynamic effects of graft-end cuts (straight, curved, and S-shaped) and graft-to-artery diameter ratios (2:1 vs. 1.5:1) have been numerically assessed in four common unexpanded anastomotic configurations with respect to vortical flow patterns, wall shear stress based parameters, and platelet interactions with the vascular surface. Sites of significant platelet-wall interactions have been identified by a novel near-wall residence time (NWRT) model, which includes shear stress based factors for platelet activation and endothelial cell expression of anti-thrombogenic compounds. Of the configurations evaluated, straight and curved graft-end cuts with a graft-to-artery diameter ratio of 1.5:1 were found to reduce the particle-hemodynamic potential for IH development at locations critical to flow delivery. Nevertheless, the potential for significant IH occurrence via platelet and/or endothelial response pathways was highly evident in all conventional anastomoses considered, such that a decisively superior configuration was not determined. These results illustrate the need for alternative anastomotic designs with the intent of reducing critical hemodynamic wall parameters and mitigating regions of significant particle-wall interactions.

Entities:  

Mesh:

Year:  2003        PMID: 14630472     DOI: 10.1016/s1350-4533(03)00124-3

Source DB:  PubMed          Journal:  Med Eng Phys        ISSN: 1350-4533            Impact factor:   2.242


  7 in total

1.  Numerical Simulation of Physiological Blood Flow in 2-way Coronary Artery Bypass Grafts.

Authors:  Aike Qiao; Youjun Liu; Siyang Li; Hu Zhao
Journal:  J Biol Phys       Date:  2005-05       Impact factor: 1.365

Review 2.  Recent advances in computational methodology for simulation of mechanical circulatory assist devices.

Authors:  Alison L Marsden; Yuri Bazilevs; Christopher C Long; Marek Behr
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2014-01-21

3.  Simulation of the microscopic process during initiation of stent thrombosis.

Authors:  Jennifer K W Chesnutt; Hai-Chao Han
Journal:  Comput Biol Med       Date:  2014-11-15       Impact factor: 4.589

Review 4.  Lagrangian postprocessing of computational hemodynamics.

Authors:  Shawn C Shadden; Amirhossein Arzani
Journal:  Ann Biomed Eng       Date:  2014-07-25       Impact factor: 3.934

5.  Computational simulation of platelet interactions in the initiation of stent thrombosis due to stent malapposition.

Authors:  Jennifer K W Chesnutt; Hai-Chao Han
Journal:  Phys Biol       Date:  2016-01-20       Impact factor: 2.583

6.  An extended convection diffusion model for red blood cell-enhanced transport of thrombocytes and leukocytes.

Authors:  S J Hund; J F Antaki
Journal:  Phys Med Biol       Date:  2009-10-07       Impact factor: 3.609

7.  Distal end side-to-side anastomoses of sequential vein graft to small target coronary arteries improve intraoperative graft flow.

Authors:  Haitao Li; Baodong Xie; Chengxiong Gu; Mingxin Gao; Fan Zhang; Jiayang Wang; Longsheng Dai; Yang Yu
Journal:  BMC Cardiovasc Disord       Date:  2014-05-09       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.